<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib124">
 <element-citation publication-type="journal" id="sref124">
  <person-group person-group-type="author">
   <name>
    <surname>Ressaissi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Attia</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Fal√©</surname>
    <given-names>P.L.</given-names>
   </name>
   <name>
    <surname>Pacheco</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Victor</surname>
    <given-names>B.L.</given-names>
   </name>
   <name>
    <surname>Machuqueiro</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Serralheiro</surname>
    <given-names>M.L.M.</given-names>
   </name>
  </person-group>
  <article-title>Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies</article-title>
  <source>Arch Pharm. Res. (Seoul)</source>
  <volume>40</volume>
  <year>2017</year>
  <fpage>1278</fpage>
  <lpage>1286</lpage>
  <ext-link ext-link-type="uri" xlink:href="https://doi:%2010.1007/s12272-017-0959-1" id="intref0545" xmlns:xlink="http://www.w3.org/1999/xlink">https://doi: 10.1007/s12272-017-0959-1</ext-link>
 </element-citation>
</ref>
